MARY BUNDLE: Open Payments
NPI 1073598686 · RICHLANDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 16 payments from 7 companies in 2025. Trend: 2023 $308 · 2024 $404 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Amgen Inc. | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: TRELEGY ELLIPTA, BREZTRI, AIRSUPRA, OTEZLA, REPATHA, VOQUEZNA, Wegovy, XIFAXAN.
Industry payments across NC — which companies pay providers there.
